Item 2.02 Results of Operations and Financial Condition.
On May 6, 2021, Albireo Pharma, Inc. issued a press release announcing its
financial results for the first quarter ended March 31, 2021 and providing a
business update. The full text of the press release is furnished as Exhibit 99.1
to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K (including Exhibit 99.1)
shall not be deemed to be "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a
Item 9.01 Financial Statements and Exhibits.
The following exhibit is furnished with this report:
Exhibit Number Description
99.1 Press release dated May 6, 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source Glimpses